Home Newsfeeds Castle Biosciences Sees FY Revenue $255M-$330M

Castle Biosciences Sees FY Revenue $255M-$330M

-Reuters

byMichael Horton

September 20, 2022

1 minute read

-Reuters

Solana-Based Shiba Inu Rival ‘Dogwifhat’ Rockets 35% As Binance Introduces WIF Futures Contract

By Mehab Qureshi

January 18, 5:01 AM

Meme coin Dogwifhat (CRYPTO: WIF), part of the Solana (CRYPTO: SOL) blockchain, experienced a 35% increase in its value within the last 24 hours, surpassing performance compared to top meme cryptocurrencies such as Dogecoin </

$BONK

News

Eli Lilly and Co’s Zepbound (Tirzepatide) Injection is Now Available in US Pharmacies for Adults Living with Obesity, Effective December 15 Zepbound Will Be Added To Cigna Healthcare’s Commercial Formularies

By Benzinga Newsdesk

December 5, 8:41 AM

Eli Lilly and Company (NYSE:LLY) today announced that Zepbound™ (tirzepatide) injection is now available. Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m2 or greater), or those who

LLY